Rachael Stolzenberg-Solomon
Overview
Explore the profile of Rachael Stolzenberg-Solomon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
85
Citations
3528
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Arjani S, Saint-Maurice P, Julian-Serrano S, Eibl G, Stolzenberg-Solomon R
JNCI Cancer Spectr
. 2022 Oct;
6(6).
PMID: 36255251
Background: Body mass index (BMI) during adulthood has been associated with pancreatic ductal adenocarcinoma (PDAC), however, patterns of body size across the adult life course have not been studied extensively....
12.
Naudin S, Sampson J, Moore S, Stolzenberg-Solomon R
Am J Epidemiol
. 2022 Jun;
191(11):1926-1935.
PMID: 35699209
Epidemiological studies using lipidomic approaches can identify lipids associated with exposures and diseases. We evaluated the sources of variability of lipidomic profiles measured in blood samples and the implications when...
13.
Julian-Serrano S, Reedy J, Robien K, Stolzenberg-Solomon R
Am J Epidemiol
. 2022 Apr;
191(9):1584-1600.
PMID: 35474368
Few prospective studies have examined associations between diet quality and pancreatic ductal adenocarcinoma (PDAC), or comprehensively compared diet quality indices. We conducted a prospective analysis of adherence to the Healthy...
14.
Corlin L, Ruan M, Tsilidis K, Bouras E, Yu Y, Stolzenberg-Solomon R, et al.
JNCI Cancer Spectr
. 2021 Jul;
5(3).
PMID: 34222791
Background: Observational studies indicate that periodontal disease may increase the risk of colorectal, lung, and pancreatic cancers. Using a 2-sample Mendelian randomization (MR) analysis, we assessed whether a genetic predisposition...
15.
Stolzenberg-Solomon R
J Natl Cancer Inst
. 2021 Mar;
113(9):1123-1124.
PMID: 33739407
No abstract available.
16.
Mocci E, Kundu P, Wheeler W, Arslan A, Beane-Freeman L, Bracci P, et al.
Cancer Res
. 2021 Feb;
81(11):3134-3143.
PMID: 33574088
Germline variation and smoking are independently associated with pancreatic ductal adenocarcinoma (PDAC). We conducted genome-wide smoking interaction analysis of PDAC using genotype data from four previous genome-wide association studies in...
17.
Yuan F, Hung R, Walsh N, Zhang H, Platz E, Wheeler W, et al.
Cancer Res
. 2020 Jul;
80(18):4004-4013.
PMID: 32641412
Registry-based epidemiologic studies suggest associations between chronic inflammatory intestinal diseases and pancreatic ductal adenocarcinoma (PDAC). As genetic susceptibility contributes to a large proportion of chronic inflammatory intestinal diseases, we hypothesize...
18.
Zhu J, Shu X, Guo X, Liu D, Bao J, Milne R, et al.
Cancer Epidemiol Biomarkers Prev
. 2020 May;
29(7):1501-1508.
PMID: 32439797
Background: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies, with few known risk factors and biomarkers. Several blood protein biomarkers have been linked to PDAC in previous...
19.
Jackson S, Adami H, Andreotti G, Beane-Freeman L, Berrington de Gonzalez A, Buring J, et al.
J Hepatol
. 2020 May;
73(4):863-872.
PMID: 32437829
Background & Aims: Gallbladder cancer (GBC) is known to have a female predominance while other biliary tract cancers (BTCs) have a male predominance. However, the role of female reproductive factors...
20.
Stolzenberg-Solomon R, Derkach A, Moore S, Weinstein S, Albanes D, Sampson J
Gut
. 2020 Feb;
69(11):2008-2015.
PMID: 32060129
Objective: To assess whether prediagnostic metabolites were associated with incident pancreatic ductal adenocarcinoma (PDAC) in a prospective cohort study. Design: We conducted an untargeted analysis of 554 known metabolites measured...